← Back to Clinical Trials
Recruiting NCT06746415

NCT06746415 The Effect of Robot-assisted Gait Training in Individuals With Chronic Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06746415
Status Recruiting
Phase
Sponsor Biruni University
Condition Chronic Stroke
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-12-01
Primary Completion 2025-01-15

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Conventional Gait TrainingRobotic Gait Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-12-01 with a primary completion date of 2025-01-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of our study was to investigate the effect of robot-assisted gait training on quadriceps muscle thickness, balance and gait parameters in individuals with chronic stroke. For these purposes:-Improving gait and balance functions of patients with chronic stroke,-Increasing functional independence in daily life with walking trainings-Increase lower extremity muscle thickness with walking training, To investigate the effects of robot-assisted gait training on quadriceps muscle thickness, balance and gait parameters in individuals with chronic stroke.-It is aimed to contribute to the literature in this field by transforming the results to be obtained as a result of the study into a scientific publication

Eligibility Criteria

Inclusion Criteria: * a history of cerebrovascular accident at least 6 months ago; * a score of at least 20 on the mini mental test; * no botulinum toxin treatment for the last 3 months; * a score of 2 or above on the Functional Ambulation Scale; * a score of 3 or above on the Brunnstrom motor staging scale in terms of lower extremity recovery level Exclusion Criteria: * presence of concomitant neurologic, orthopedic, cardiovascular disease and acute comorbidities * severe spasticity of lower extremity muscles, more than 2 on the Modified Ashworth Scale

Contact & Investigator

Central Contact

Güzin Kaya Aytutuldu

✉ guzinkaya14@gmail.com

📞 05366265884

Frequently Asked Questions

Who can join the NCT06746415 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 75 Years, studying Chronic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06746415 currently recruiting?

Yes, NCT06746415 is actively recruiting participants. Contact the research team at guzinkaya14@gmail.com for enrollment information.

Where is the NCT06746415 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06746415 clinical trial?

NCT06746415 is sponsored by Biruni University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology